We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+14.37%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$70.3B
AUM Growth
+$5.01B
Cap. Flow
-$2.71B
Cap. Flow %
-3.85%
Top 10 Hldgs %
44.08%
Holding
1,018
New
48
Increased
188
Reduced
438
Closed
322

Sector Composition

Rank Sector Weight
1 Technology 27.76%
2 Communication Services 17.95%
3 Consumer Discretionary 15.08%
4 Healthcare 13.08%
5 Financials 9.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTSI icon
76
MACOM Technology Solutions
MTSI
$23.7B
$77.4M 0.11%
809,640
-25,787
-3% -$2.28M
KNSL icon
77
Kinsale Capital Group
KNSL
$8.51B
$76.3M 0.11%
145,396
-2,968
-2% -$1.34M
HQY icon
78
HealthEquity
HQY
$8.75B
$76M 0.11%
930,866
+50,212
+6% +$3.92M
WEX icon
79
WEX
WEX
$6.31B
$74.2M 0.11%
312,581
-1,709
-0.5% -$368K
AEIS icon
80
Advanced Energy
AEIS
$13B
$73.9M 0.11%
725,047
-14,264
-2% -$1.45M
BRBR icon
81
BellRing Brands
BRBR
$1.34B
$73.1M 0.1%
1,238,788
-33,709
-3% -$1.92M
SLAB icon
82
Silicon Laboratories
SLAB
$7.23B
$71.8M 0.1%
499,419
-10,930
-2% -$1.45M
CWST icon
83
Casella Waste Systems
CWST
$5.69B
$71.7M 0.1%
724,954
-23,074
-3% -$2.07M
MGY icon
84
Magnolia Oil & Gas
MGY
$5.94B
$70.4M 0.1%
2,714,640
-52,440
-2% -$1.15M
CRSP icon
85
CRISPR Therapeutics
CRSP
$5.17B
$69.9M 0.1%
1,025,243
-42,108
-4% -$3.01M
EVH icon
86
Evolent Health
EVH
$447M
$69.2M 0.1%
2,111,115
+115,503
+6% +$3.69M
DOCS icon
87
Doximity
DOCS
$4.88B
$68.2M 0.1%
2,532,564
-96,555
-4% -$2.75M
PRCT icon
88
Procept Biorobotics
PRCT
$1.17B
$66.8M 0.1%
1,351,000
+34,292
+3% +$1.63M
ACHC icon
89
Acadia Healthcare
ACHC
$2.94B
$66.3M 0.09%
836,411
+41,739
+5% +$3.41M
AIT icon
90
Applied Industrial Technologies
AIT
$13.3B
$64.7M 0.09%
327,261
-10,469
-3% -$1.91M
MEDP icon
91
Medpace
MEDP
$16.5B
$64.2M 0.09%
158,774
-5,100
-3% -$1.79M
VRNS icon
92
Varonis Systems
VRNS
$5B
$63.1M 0.09%
1,337,906
-42,638
-3% -$2.03M
VEEV icon
93
Veeva Systems
VEEV
$37.4B
$62.9M 0.09%
271,617
-12,317
-4% -$2.66M
KBR icon
94
KBR
KBR
$4.8B
$62.7M 0.09%
984,377
-204,555
-17% -$11.6M
AIN icon
95
Albany International
AIN
$1.78B
$62.5M 0.09%
668,635
-18,989
-3% -$1.74M
ONTO icon
96
Onto Innovation
ONTO
$15.3B
$62.3M 0.09%
343,849
-10,935
-3% -$1.85M
NE icon
97
Noble Corp
NE
$6.51B
$58.3M 0.08%
1,202,493
-34,956
-3% -$1.57M
WK icon
98
Workiva
WK
$3.54B
$58.3M 0.08%
687,126
-13,882
-2% -$1.25M
FCN icon
99
FTI Consulting
FCN
$4.18B
$58M 0.08%
275,989
-41,747
-13% -$8.39M
UTHR icon
100
United Therapeutics
UTHR
$23.1B
$57.9M 0.08%
252,024
-2,020
-0.8% -$456K

Similar funds

Loomis, Sayles & Company's Q1 2024 Portfolio in Review

As of Q1 2024, Loomis, Sayles & Company held 1,018 positions worth $70.3B, up 7.7% from $65.3B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Loomis, Sayles & Company withdrew a net $2.71B in Q1 2024, closing 322 positions and reducing 438 holdings. Its most notable exit was WillScot Mobile Mini Holdings, an estimated $64.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Loomis, Sayles & Company opened a new position in Natixis Loomis Sayles Focused Growth ETF worth $137M.

  • Loomis, Sayles & Company's largest Q1 2024 buy was Natixis Loomis Sayles Focused Growth ETF: 4,284,398 shares worth $137M.
  • Loomis, Sayles & Company added most to Tesla in Q1 2024, an estimated $819M increase.
  • Loomis, Sayles & Company's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.94B.
  • Loomis, Sayles & Company fully exited WillScot Mobile Mini Holdings in Q1 2024, selling an estimated $64.3M.
  • Loomis, Sayles & Company's ten largest holdings make up 44% of its $70.3B portfolio in Q1 2024.
  • Loomis, Sayles & Company opened 48 new positions and closed 322 in Q1 2024.
  • Loomis, Sayles & Company's portfolio value rose 7.7% quarter-over-quarter to $70.3B.

Based on Loomis, Sayles & Company's 13F filing for Q1 2024, filed 14 May 2024.